CITIUS ONCOLOGY, INC. (NASDAQ:CTOR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 13, 2026.
The Healthcare company reported Q0 revenue of .
CITIUS ONCOLOGY, INC.'s stock currently trades at $1.22 with a market capitalization of $96.0M.